Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ypsomed Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Electromed, Inc. Logo
Develops HFCWO airway clearance systems for patients with chronic lung conditions.
United States of America
ELMD
elexxion AG Logo
Manufactures advanced dental lasers for minimally invasive and low-pain procedures.
Germany
EX8
Elos Medtech Logo
A global CDMO for dental, orthopedic, & surgical devices, offering end-to-end solutions.
Sweden
ELOS
Embecta Corp. Logo
Global producer of diabetes injection devices, like pen needles and syringes, for 30M+ people.
United States of America
EMBC
Embla Medical hf Logo
Global provider of non-invasive orthopedics, prosthetics, and mobility solutions.
Iceland
EMBLA
Enovis CORP Logo
Develops orthopedic solutions for prevention, surgical intervention, and rehabilitation.
United States of America
ENOV
Envista Holdings Corp Logo
A global provider of comprehensive dental products, from implants and aligners to equipment.
United States of America
NVST
Envoy Medical, Inc. Logo
Develops innovative, fully-implanted hearing devices that use the ear's natural anatomy.
United States of America
COCH
enVVeno Medical Corp Logo
Develops bioprosthetic venous valves for treating severe Chronic Venous Insufficiency.
United States of America
NVNO
EOFlow Co., Ltd. Logo
Develops wearable, tubeless insulin patch-pumps for affordable and user-friendly diabetes management.
South Korea
294090

Talk to a Data Expert

Have a question? We'll get back to you promptly.